甲状腺癌中的生物标志物:来自非编码RNA和线粒体空间的新兴机会
Patricio Cabané1,2,3, Claudio Correa1,2, Ignacio Bode4
1Department of Head and Neck Surgery, Clinica INDISA, Santiago 7520440, Chile.
International journal of molecular sciences
|June 27, 2024
概括
新的分子标记物正在评估,以改善甲状腺癌的诊断和预后. 这些标记物,包括microRNAs和线粒体DNA签名,旨在克服当前测试的局限性,以更好地评估患者.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 甲状腺癌的诊断依赖于成像和细胞学,分子标记物有助于不确定的病例.
- 目前的分子测试面临成本和可变性方面的挑战,限制了广泛采用.
- 需要新的分子标记物来提高诊断确定性和预后准确性.
研究的目的:
- 审查当前的甲状腺癌手术前检测方法.
- 综合评估新兴的分子标记物,以改善诊断和预后.
- 讨论微RNA,长非编码RNA和线粒体特征的潜力.
主要方法:
- 在甲状腺癌当前的诊断技术的审查.
- 关于新兴分子标记物的综合文献综述.
- 专注于微RNA,长非编码RNA和线粒体特征 (mtDNA基因,无细胞mtDNA).
主要成果:
- 目前的分子测试在成本和可变性方面存在局限性.
- 像microRNAs和mtDNA签名这样的新兴标记物显示出改善诊断确定性的承诺.
- 这些标志物可以帮助评估癌症的攻击性和复发风险.
结论:
- 新型分子标记物对于提高甲状腺癌诊断和预后至关重要.
- 微RNA,lncRNA和线粒体特征代表着有前途的研究领域.
- 一个强大的分子标记物小组可以补充现有的疾病评估临床指南.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
02:55The Nucleolus
8.8K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K